Literature DB >> 9234067

Methioninase: a therapeutic for diseases related to altered methionine metabolism and transmethylation: cancer, heart disease, obesity, aging, and Parkinson's disease.

R M Hoffman1.   

Abstract

Methionine metabolism and transmethylation are central to the metabolism and differentiation of all known cells. In enkaryotic organisms, methionine metabolism and transmethylation are of paramount importance in modification and regulation of proteins, lipids, and nucleic acids. The differential methylation of genes regulates their expression in the myriad of cells in eukaryotic organisms. Disruption and abnormalities in methionine metabolism and transmethylation seems to be associated with the major diseases of mankind, including cancer, heart disease, aging, obesity, and Parkinson's disease. In this review, we describe how aberrant and abnormal methionine metabolism and transmethylation are related to these major diseases. Most importantly, we review and hypothesize how the developing therapeutic recombination methioninase (rMETase) can be utilized to cure or prevent all of these diseases.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9234067

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  6 in total

1.  Pre-steady-state kinetic and structural analysis of interaction of methionine γ-lyase from Citrobacter freundii with inhibitors.

Authors:  Nikita A Kuznetsov; Nicolai G Faleev; Alexandra A Kuznetsova; Elena A Morozova; Svetlana V Revtovich; Natalya V Anufrieva; Alexei D Nikulin; Olga S Fedorova; Tatyana V Demidkina
Journal:  J Biol Chem       Date:  2014-11-14       Impact factor: 5.157

2.  Structure of Citrobacter freundii L-methionine gamma-lyase.

Authors:  D V Mamaeva; E A Morozova; A D Nikulin; S V Revtovich; S V Nikonov; M B Garber; T V Demidkina
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-06-01

3.  SCF(Met30)-mediated control of the transcriptional activator Met4 is required for the G(1)-S transition.

Authors:  E E Patton; C Peyraud; A Rouillon; Y Surdin-Kerjan; M Tyers; D Thomas
Journal:  EMBO J       Date:  2000-04-03       Impact factor: 11.598

Review 4.  Targeting the methionine addiction of cancer.

Authors:  Joni C Sedillo; Vincent L Cryns
Journal:  Am J Cancer Res       Date:  2022-05-15       Impact factor: 5.942

5.  Data-mining analysis suggests an epigenetic pathogenesis for type 2 diabetes.

Authors:  Jonathan D Wren; Harold R Garner
Journal:  J Biomed Biotechnol       Date:  2005-06-30

6.  A global characterization of the translational and transcriptional programs induced by methionine restriction through ribosome profiling and RNA-seq.

Authors:  Ke Zou; Qi Ouyang; Hao Li; Jiashun Zheng
Journal:  BMC Genomics       Date:  2017-02-17       Impact factor: 3.969

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.